Financials data is unavailable for this security.
View more
Year on year Klaria Pharma Holding AB (publ) had revenues fall -100.00% from 5.87m to 0.00, though the company grew net income from a loss of 63.77m to a smaller loss of 35.78m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -24.10% |
---|---|
Return on equity | -44.74% |
Return on investment | -44.74% |
More ▼
Cash flow in SEKView more
In 2023, cash reserves at Klaria Pharma Holding AB (publ) fell by 15.51m. However, Cash Flow from Investing was flat, indicating that little new money was committed to growth. In addition the company used 9.06m for operations while cash used for financing totalled 6.46m.
Cash flow per share | -0.2197 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.1603 |
---|---|
Tangible book value per share | 0.1603 |
More ▼
Balance sheet in SEKView more
Current ratio | 1.46 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼